AMGN compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

ADPT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±14.5%▲+0.45%×0.03

Q2 FY26±15.2%▲+7.18%×0.47

= impliedAMGN realized, solidADPT realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Q1 FY26±16.2%▲+4.72%×0.29

Feb 6 '26±13.4%▼−4.25%×0.32

AMGNAmgen Inc

462.17▲+0.38%

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ADPTAdaptive Biotechnologies Corp

30.22▲+8.00%

Regular sessionNov 9 '26

Mkt cap$4.5BRevenue$84MQ3 FY26Revenue$277MFY25

Compare

Regular sessionNov 9 '26

AMGNAmgen Inc

ADPTAdaptive Biotechnologies Corp

462.17▲+0.38%

Price

30.22▲+8.00%

$249.0B

Mkt cap

$4.5B

Q3 FY26$10.4B

Revenue

$84MQ3 FY26

FY25$36.8B

Revenue

$277MFY25

AMGN462.17▲+0.38%vsADPT30.22▲+8.00%Regular sessionNov 9 '26